Swan Capital’s Transmedics TMDX Stock Holding History

Swan Capital’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$795	Hold	8	–	–	﹤0.01%	466
2025 Q4	$973	Buy	+8	New	+$1K	﹤0.01%	406

Other funds holding TMDX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Swan Capital's TMDX Position: Q1 2026 in Review

Swan Capital held its Transmedics (TMDX) position steady in Q1 2026 at 8 shares worth $795. The position accounts for ﹤0.01% of the portfolio, ranked #466.

Swan Capital first reported a position in TMDX in Q4 2025 and has held it in 2 quarters since. The position peaked at $973 in Q4 2025. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

Swan Capital held 8 shares of Transmedics worth $795 as of Q1 2026.
Swan Capital left its Transmedics share count unchanged in Q1 2026.
Transmedics made up ﹤0.01% of Swan Capital's portfolio in Q1 2026, its #466 holding.
Swan Capital first reported a position in Transmedics in Q4 2025 and has held it in 2 quarters since.
Swan Capital's Transmedics position peaked at $973 in Q4 2025.
414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Swan Capital's 13F filing for Q1 2026, filed 14 May 2026.